These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 31000370

  • 1. Brain gliomas, hydrocephalus and idiopathic aqueduct stenosis in children with neurofibromatosis type 1.
    Glombova M, Petrak B, Lisy J, Zamecnik J, Sumerauer D, Liby P.
    Brain Dev; 2019 Sep; 41(8):678-690. PubMed ID: 31000370
    [Abstract] [Full Text] [Related]

  • 2. Clinical Presentation and Outcome of Patients With Optic Pathway Glioma.
    Robert-Boire V, Rosca L, Samson Y, Ospina LH, Perreault S.
    Pediatr Neurol; 2017 Oct; 75():55-60. PubMed ID: 28847625
    [Abstract] [Full Text] [Related]

  • 3. Pretreatment Endocrine Disorders Due to Optic Pathway Gliomas in Pediatric Neurofibromatosis Type 1: Multicenter Study.
    Santoro C, Perrotta S, Picariello S, Scilipoti M, Cirillo M, Quaglietta L, Cinalli G, Cioffi D, Di Iorgi N, Maghnie M, Gallizia A, Parpagnoli M, Messa F, De Sanctis L, Vannelli S, Marzuillo P, Miraglia Del Giudice E, Grandone A.
    J Clin Endocrinol Metab; 2020 Jun 01; 105(6):. PubMed ID: 32294191
    [Abstract] [Full Text] [Related]

  • 4. Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas.
    Chang L, El-Dairi MA, Frempong TA, Burner EL, Bhatti MT, Young TL, Leigh F.
    J AAPOS; 2010 Dec 01; 14(6):511-7. PubMed ID: 21168074
    [Abstract] [Full Text] [Related]

  • 5. Serial MRIs provide novel insight into natural history of optic pathway gliomas in patients with neurofibromatosis 1.
    Sellmer L, Farschtschi S, Marangoni M, Heran MKS, Birch P, Wenzel R, Mautner VF, Friedman JM.
    Orphanet J Rare Dis; 2018 Apr 23; 13(1):62. PubMed ID: 29685181
    [Abstract] [Full Text] [Related]

  • 6. Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.
    Byrne S, Connor S, Lascelles K, Siddiqui A, Hargrave D, Ferner RE.
    J Neurooncol; 2017 Jul 23; 133(3):609-614. PubMed ID: 28593402
    [Abstract] [Full Text] [Related]

  • 7. Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy.
    Sharif S, Ferner R, Birch JM, Gillespie JE, Gattamaneni HR, Baser ME, Evans DG.
    J Clin Oncol; 2006 Jun 01; 24(16):2570-5. PubMed ID: 16735710
    [Abstract] [Full Text] [Related]

  • 8. Optic Pathway Gliomas in Neurofibromatosis Type 1.
    Campen CJ, Gutmann DH.
    J Child Neurol; 2018 Jan 01; 33(1):73-81. PubMed ID: 29246098
    [Abstract] [Full Text] [Related]

  • 9. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
    Segal L, Darvish-Zargar M, Dilenge ME, Ortenberg J, Polomeno RC.
    J AAPOS; 2010 Apr 01; 14(2):155-8. PubMed ID: 20451859
    [Abstract] [Full Text] [Related]

  • 10. Visual acuity of children treated with chemotherapy for optic pathway gliomas.
    Kalin-Hajdu E, Décarie JC, Marzouki M, Carret AS, Ospina LH.
    Pediatr Blood Cancer; 2014 Feb 01; 61(2):223-7. PubMed ID: 23956233
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1.
    Prada CE, Hufnagel RB, Hummel TR, Lovell AM, Hopkin RJ, Saal HM, Schorry EK.
    J Pediatr; 2015 Oct 01; 167(4):851-856.e1. PubMed ID: 26233602
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intracranial gliomas in neurofibromatosis type 1.
    Listernick R, Charrow J, Gutmann DH.
    Am J Med Genet; 1999 Mar 26; 89(1):38-44. PubMed ID: 10469435
    [Abstract] [Full Text] [Related]

  • 15. Natural history and outcome of optic pathway gliomas in children.
    Nicolin G, Parkin P, Mabbott D, Hargrave D, Bartels U, Tabori U, Rutka J, Buncic JR, Bouffet E.
    Pediatr Blood Cancer; 2009 Dec 15; 53(7):1231-7. PubMed ID: 19621457
    [Abstract] [Full Text] [Related]

  • 16. Measurements of Retinal Nerve Fiber Thickness and Ganglion Cell Complex in Neurofibromatosis Type 1, with and Without Optic Pathway Gliomas: A Case Series.
    Sahinoglu-Keskek N, Altan-Yaycioglu R, Canan H, Coban-Karatas M, Erbay A, Yazıcı N, Alkan O.
    Curr Eye Res; 2018 Mar 15; 43(3):424-427. PubMed ID: 29185816
    [Abstract] [Full Text] [Related]

  • 17. Peri-gestational risk factors for pediatric brain tumors in Neurofibromatosis Type 1.
    Johnson KJ, Zoellner NL, Gutmann DH.
    Cancer Epidemiol; 2016 Jun 15; 42():53-9. PubMed ID: 27018750
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Optic pathway glioma and endocrine disorders in patients with and without NF1.
    Gil Margolis M, Yackobovitz-Gavan M, Toledano H, Tenenbaum A, Cohen R, Phillip M, Shalitin S.
    Pediatr Res; 2023 Jan 15; 93(1):233-241. PubMed ID: 35538247
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.